Advanced search
Publication Cover
Expert Opinion on Pharmacotherapy Volume 16, 2015 - Issue 12
Submit an article Journal homepage
819
Views
8
CrossRef citations to date
0
Altmetric
Drug Evaluations

An update on the use of lenalidomide for the treatment of multiple myeloma

Flora ZagouriNational and Kapodistrian University of Athens, School of Medicine, Department of Clinical Therapeutics, 80 Vas. Sofias Ave, Athens 11528, Greece+302 103 381 541; +302 132 162 511; [email protected]
, MD PhD,
Evangelos TerposNational and Kapodistrian University of Athens, School of Medicine, Department of Clinical Therapeutics, 80 Vas. Sofias Ave, Athens 11528, Greece+302 103 381 541; +302 132 162 511; [email protected]
, MD PhD,
Efstathios KastritisNational and Kapodistrian University of Athens, School of Medicine, Department of Clinical Therapeutics, 80 Vas. Sofias Ave, Athens 11528, Greece+302 103 381 541; +302 132 162 511; [email protected]
, MD PhD &
Meletios-Athanasios DimopoulosNational and Kapodistrian University of Athens, School of Medicine, Department of Clinical Therapeutics, 80 Vas. Sofias Ave, Athens 11528, Greece+302 103 381 541; +302 132 162 511; [email protected]
, MD PhD
Pages 1865-1877 | Published online: 13 Jul 2015

Citations (8)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Flora Zagouri, Evangelos Terpos, Efstathios Kastritis & Meletios A. Dimopoulos. (2016) Emerging antibodies for the treatment of multiple myeloma. Expert Opinion on Emerging Drugs 21:2, pages 225-237.
Read now

Articles from other publishers (7)

ShankarLal Chahar, Sidharth Mani, Jandhyala Sridhar & Padmapriya Srinivasan. (2021) Lenalidomide in a case of thalidomide intolerant erythema nodosum leprosum. Indian Journal of Drugs in Dermatology 7:2, pages 84.
Crossref
Lu-Yang Fu, Jun Ying, Xinxin Qi, Jin-Bao Peng & Xiao-Feng Wu. (2019) Palladium-Catalyzed Carbonylative Synthesis of Isoindolinones from Benzylamines with TFBen as the CO Source. The Journal of Organic Chemistry 84:3, pages 1421-1429.
Crossref
Ota Fuchs. (2019) Treatment of Lymphoid and Myeloid Malignancies by Immunomodulatory Drugs. Cardiovascular & Hematological Disorders-Drug Targets 19:1, pages 51-78.
Crossref
Johan Lund, Astrid Gruber, Birgitta Lauri, Adil Doganay Duru, Cecilie Blimark, Agneta Swedin, Markus Hansson, Karin Forsberg, Lucia Ahlberg, Conny Carlsson, Anders Waage, Peter Gimsing, Annette Juul Vangsted, Ulf Frølund, Erik Holmberg, Gösta Gahrton, Evren Alici, Mats Hardling, Ulf‐Henrik Mellqvist & Hareth Nahi. (2018) Lenalidomide versus lenalidomide + dexamethasone prolonged treatment after second‐line lenalidomide + dexamethasone induction in multiple myeloma. Cancer Medicine 7:6, pages 2256-2268.
Crossref
Massimo Giuliani, Bassam Janji & Guy Berchem. (2017) Activation of NK cells and disruption of PD-L1/PD-1 axis: two different ways for lenalidomide to block myeloma progression. Oncotarget 8:14, pages 24031-24044.
Crossref
Noopur S. Raje, Philippe Moreau, Evangelos Terpos, Lotfi Benboubker, Norbert Grząśko, Sarah A. Holstein, Albert Oriol, Shang-Yi Huang, Meral Beksac, Kazimierz Kuliczkowski, Datchen F. Tai, James E. Wooldridge, Ilaria Conti, Christopher J. Kaiser, Tuan S. Nguyen, Damien M. Cronier & Antonio Palumbo. (2017) Phase 2 study of tabalumab, a human anti-B-cell activating factor antibody, with bortezomib and dexamethasone in patients with previously treated multiple myeloma. British Journal of Haematology 176:5, pages 783-795.
Crossref
Nianhang Chen, Simon Zhou & Maria Palmisano. (2016) Clinical Pharmacokinetics and Pharmacodynamics of Lenalidomide. Clinical Pharmacokinetics 56:2, pages 139-152.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.